After one year of follow-up, a 65-center, 10-nation clinical study reinforces earlier findings that weekly dupilumab treatment for eosinophilic esophagitis produces stronger histologic, symptomatic, endoscopic, and molecular improvements compared to treatment every two weeks. Results from the study, led by Cincinnati Children’s physician–scientist Marc Rothenberg, MD, PhD, from Cincinnati Children’s, were published online Aug. 31, 2023 in The Lancet: Gastroenterology and Hepatology.
Read the Research Horizon science blog post.
Mario Ynga Durand Receives Arnold Strauss Research Fellowship
Congratulations to Mario Ynga Durand, MD, PhD, research fellow in the Rothenberg CURED Lab, for receiving a 2023 Arnold W. Strauss Research Fellowship for his project "TSLP-Mediated Mechanisms of Epithelial Dysregulation in Eosinophilic Esophagitis". Read the Inspire In the Spotlight award announcement.